These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26888011)

  • 21. Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods.
    Allen LV
    Int J Pharm Compd; 2022; 26(6):490-495. PubMed ID: 36445768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
    Xie Y; Xu B; Gao Y
    Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations.
    Pearton M; Allender C; Brain K; Anstey A; Gateley C; Wilke N; Morrissey A; Birchall J
    Pharm Res; 2008 Feb; 25(2):407-16. PubMed ID: 17671832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal Delivery of Nucleic Acid Mediated by Punching and Electroporation.
    Huang D; Huang Y; Li Z
    Methods Mol Biol; 2020; 2050():101-112. PubMed ID: 31468484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parameter optimization toward optimal microneedle-based dermal vaccination.
    van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
    Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on transdermal delivery of ferulic acid through rat skin treated by microneedle arrays].
    Yang B; Du SY; Bai J; Shang KX; Lu Y; Li PY
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(24):4773-7. PubMed ID: 25898576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of a novel transdermal delivery system of peptide and protein drugs using microneedle arrays].
    Katsumi H; Quan YS; Kamiyama F; Kusamori K; Sakane T; Yamamoto A
    Yakugaku Zasshi; 2014; 134(1):63-7. PubMed ID: 24389619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro.
    Donnelly RF; Singh TR; Tunney MM; Morrow DI; McCarron PA; O'Mahony C; Woolfson AD
    Pharm Res; 2009 Nov; 26(11):2513-22. PubMed ID: 19756972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine.
    Pearson FE; O'Mahony C; Moore AC; Hill AV
    Vaccine; 2015 Jun; 33(28):3248-55. PubMed ID: 25839104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer.
    Donnelly RF; Morrow DI; McCarron PA; David Woolfson A; Morrissey A; Juzenas P; Juzeniene A; Iani V; McCarthy HO; Moan J
    Photochem Photobiol; 2009; 85(1):195-204. PubMed ID: 18764907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
    Cahill EM; O'Cearbhaill ED
    Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD).
    Gonzalez-Gonzalez E; Speaker TJ; Hickerson RP; Spitler R; Flores MA; Leake D; Contag CH; Kaspar RL
    Mol Ther; 2010 Sep; 18(9):1667-74. PubMed ID: 20571543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
    Li G; Badkar A; Nema S; Kolli CS; Banga AK
    Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facial skin barrier function recovery after microneedle transdermal delivery treatment.
    Han TY; Park KY; Ahn JY; Kim SW; Jung HJ; Kim BJ
    Dermatol Surg; 2012 Nov; 38(11):1816-22. PubMed ID: 22882208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Punching and Electroporation for Enhanced Transdermal Drug Delivery.
    Yang G; Zhang Y; Gu Z
    Theranostics; 2018; 8(13):3688-3690. PubMed ID: 30026875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans.
    Hiraishi Y; Hirobe S; Iioka H; Quan YS; Kamiyama F; Asada H; Okada N; Nakagawa S
    J Control Release; 2013 Oct; 171(2):93-103. PubMed ID: 23791975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.